Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Inflarx NV
Inflarx NV logo

IFRX - Inflarx NV Share News

$4.29 -0.0  -0.5%

Last Trade - 02/03/21

Sector
Healthcare
RiskRating
Speculative
Size
Small Cap
Style
Sucker Stock
Market Cap £133.8m
Enterprise Value £51.9m
Revenue £n/a
Position in Universe 4494th / 6633
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions IFRX Dividends
All News
All News Reuters News Company Announcements
InflaRx Announces Closing of $75 Million Public Offering of Common Shares and One-Year Warrants
Mon 9:01pm News
BRIEF-Inflarx Announces Pricing Of $75 Million Public Offering Of Common Shares And One-Year Warrants
Thu 2:39pm News
InflaRx Announces Pricing of $75 Million Public Offering of Common Shares and One-Year Warrants
Thu 1:30pm News
BRIEF-InflaRx Reports Proposed Offering of Common Shares and One-Year Warrants
24th Feb News
InflaRx Announces Proposed Offering of Common Shares and One-Year Warrants
24th Feb News
InflaRx Announces Presentation of New C5a and Vilobelimab (IFX-1) Data from Phase IIB SHINE Study at the 2021 Virtual European Hidradenitis Suppurativa Foundation Conference
11th Feb News
BRIEF-Inflarx NV Says Phase II Trial In Patients With Cutaneous Squamous Cell Carcinoma To Start In First Half 2021
11th Jan News
InflaRx Provides Update on Vilobelimab (IFX-1) Development
11th Jan News
InflaRx to Present at Upcoming Annual J.P. Morgan Healthcare Conference
7th Jan News
BRIEF-Inflarx Completes Enrollment In Vilobelimab (Ifx-1) European Phase Ii Study In Anca-Associated Vasculitis
5th Jan News
InflaRx Completes Enrollment in Vilobelimab (IFX-1) European Phase II Study in ANCA-associated Vasculitis
5th Jan News
BRIEF-Inflarx Reports Q3 Loss Per Share EUR 0.25
29th Oct '20 News
InflaRx Reports Q3 2020 Financial & Operating Results
29th Oct '20 News
BRIEF-InflaRx NV Says Thomas Taapken Appointed CFO
17th Sep '20 News
InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer
17th Sep '20 News
BUZZ-InflaRx NV: Jumps on starting late-stage trial of potential COVID-19 treatment
14th Sep '20 News
BRIEF-InflaRx Announces Start Of Phase III Part Of Phase II/III Clinical Trial With IFX-1 In COVID-19-Induced Pneumonia
14th Sep '20 News
InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia
14th Sep '20 News
InflaRx to Present at Upcoming Virtual Investor Events
6th Aug '20 News
BRIEF-Inflarx Reports Qtrly Loss Per Share Eur 0.38
30th Jul '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.